 Amy McKee
Concepts (215)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Berylliosis | 7 | 2022 | 202 | 2.570 |
Why?
| | CD4-Positive T-Lymphocytes | 15 | 2020 | 1129 | 2.550 |
Why?
| | Dendritic Cells | 11 | 2024 | 499 | 2.200 |
Why?
| | Adjuvants, Immunologic | 9 | 2017 | 245 | 1.870 |
Why?
| | Macrophages, Alveolar | 2 | 2021 | 368 | 1.050 |
Why?
| | Th2 Cells | 7 | 2019 | 171 | 1.010 |
Why?
| | Alum Compounds | 5 | 2017 | 26 | 0.970 |
Why?
| | Beryllium | 7 | 2022 | 161 | 0.910 |
Why?
| | Apoptosis Regulatory Proteins | 4 | 2021 | 186 | 0.740 |
Why?
| | HLA-DP beta-Chains | 3 | 2019 | 87 | 0.700 |
Why?
| | Alarmins | 1 | 2021 | 27 | 0.670 |
Why?
| | Lung Injury | 2 | 2021 | 237 | 0.660 |
Why?
| | Sarcoidosis | 1 | 2022 | 160 | 0.620 |
Why?
| | Adaptive Immunity | 6 | 2022 | 169 | 0.600 |
Why?
| | Th1 Cells | 5 | 2008 | 139 | 0.590 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2019 | 114 | 0.580 |
Why?
| | Lung | 6 | 2024 | 4109 | 0.580 |
Why?
| | Cell Movement | 6 | 2018 | 965 | 0.570 |
Why?
| | Receptors, Interleukin-1 Type I | 1 | 2018 | 25 | 0.560 |
Why?
| | Immunity, Cellular | 3 | 2010 | 272 | 0.560 |
Why?
| | Toll-Like Receptor 9 | 1 | 2018 | 37 | 0.560 |
Why?
| | Hypersensitivity | 2 | 2018 | 252 | 0.550 |
Why?
| | Vaccines | 2 | 2017 | 389 | 0.550 |
Why?
| | Lymphocyte Activation | 9 | 2018 | 1126 | 0.520 |
Why?
| | Allergens | 2 | 2018 | 384 | 0.500 |
Why?
| | Antigen Presentation | 3 | 2017 | 205 | 0.490 |
Why?
| | Mice, Inbred C57BL | 17 | 2024 | 5992 | 0.490 |
Why?
| | Hypersensitivity, Delayed | 1 | 2016 | 29 | 0.490 |
Why?
| | Mice, Knockout | 12 | 2020 | 3121 | 0.450 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2016 | 364 | 0.450 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2020 | 1217 | 0.450 |
Why?
| | Lung Diseases | 1 | 2022 | 787 | 0.450 |
Why?
| | Metals | 1 | 2016 | 142 | 0.440 |
Why?
| | Immunity, Innate | 5 | 2021 | 846 | 0.440 |
Why?
| | Antibody Formation | 3 | 2017 | 294 | 0.420 |
Why?
| | Autoantigens | 1 | 2016 | 429 | 0.390 |
Why?
| | Mice | 27 | 2025 | 18339 | 0.380 |
Why?
| | Animals | 31 | 2025 | 38058 | 0.370 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 917 | 0.330 |
Why?
| | Chronic Disease | 4 | 2022 | 1813 | 0.330 |
Why?
| | Schistosoma mansoni | 6 | 2008 | 41 | 0.320 |
Why?
| | Granuloma | 3 | 2022 | 96 | 0.310 |
Why?
| | Macrophages, Peritoneal | 1 | 2009 | 89 | 0.300 |
Why?
| | Antigens | 5 | 2013 | 347 | 0.290 |
Why?
| | B-Lymphocytes | 2 | 2019 | 876 | 0.280 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.270 |
Why?
| | Schistosomiasis mansoni | 3 | 2004 | 25 | 0.270 |
Why?
| | CD40 Antigens | 4 | 2004 | 90 | 0.270 |
Why?
| | Mast Cells | 1 | 2009 | 146 | 0.270 |
Why?
| | Interleukin-4 | 1 | 2008 | 206 | 0.260 |
Why?
| | Inflammation Mediators | 2 | 2009 | 509 | 0.250 |
Why?
| | Immune System | 1 | 2007 | 179 | 0.240 |
Why?
| | DNA | 1 | 2013 | 1463 | 0.240 |
Why?
| | Antigens, Helminth | 5 | 2008 | 16 | 0.230 |
Why?
| | Ovalbumin | 4 | 2019 | 190 | 0.220 |
Why?
| | Immunologic Memory | 4 | 2011 | 366 | 0.210 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 64 | 0.210 |
Why?
| | HLA-DRB1 Chains | 1 | 2025 | 109 | 0.210 |
Why?
| | Mice, Transgenic | 8 | 2025 | 2182 | 0.210 |
Why?
| | Toxoplasmosis | 1 | 2004 | 43 | 0.210 |
Why?
| | Toxoplasma | 1 | 2004 | 49 | 0.210 |
Why?
| | Signal Transduction | 4 | 2021 | 5226 | 0.210 |
Why?
| | Immune Tolerance | 2 | 2025 | 379 | 0.200 |
Why?
| | Cells, Cultured | 8 | 2018 | 4154 | 0.200 |
Why?
| | Pneumonia | 2 | 2019 | 631 | 0.200 |
Why?
| | Cytokines | 5 | 2021 | 2061 | 0.200 |
Why?
| | Glutamic Acid | 1 | 2025 | 251 | 0.190 |
Why?
| | CD8 Antigens | 2 | 2003 | 72 | 0.180 |
Why?
| | Vaccination | 2 | 2010 | 1423 | 0.180 |
Why?
| | Collagen | 1 | 2025 | 456 | 0.180 |
Why?
| | Cell Differentiation | 6 | 2018 | 2050 | 0.180 |
Why?
| | Pyroptosis | 1 | 2021 | 5 | 0.170 |
Why?
| | Enzyme-Linked Immunospot Assay | 2 | 2018 | 37 | 0.170 |
Why?
| | Hypertension, Pulmonary | 2 | 2024 | 1980 | 0.160 |
Why?
| | Necrosis | 1 | 2021 | 244 | 0.160 |
Why?
| | Apoptosis | 2 | 2021 | 2430 | 0.160 |
Why?
| | Flow Cytometry | 4 | 2015 | 1173 | 0.160 |
Why?
| | Aluminum | 2 | 2010 | 43 | 0.150 |
Why?
| | Interleukin-1 Receptor Accessory Protein | 1 | 2019 | 9 | 0.150 |
Why?
| | Antibodies, Blocking | 1 | 2019 | 37 | 0.150 |
Why?
| | Humans | 20 | 2024 | 144759 | 0.150 |
Why?
| | Schistosomiasis | 1 | 2019 | 49 | 0.150 |
Why?
| | Peritonitis | 1 | 2019 | 84 | 0.140 |
Why?
| | Psoriasis | 1 | 2019 | 112 | 0.140 |
Why?
| | Disease Models, Animal | 4 | 2019 | 4557 | 0.140 |
Why?
| | Gene Expression Regulation | 3 | 2021 | 2608 | 0.130 |
Why?
| | Hypoxia | 1 | 2024 | 1199 | 0.120 |
Why?
| | Immunization | 1 | 2018 | 374 | 0.120 |
Why?
| | Receptors, Pattern Recognition | 1 | 2016 | 12 | 0.120 |
Why?
| | Interleukin-12 | 4 | 2004 | 117 | 0.120 |
Why?
| | Mice, Inbred BALB C | 2 | 2009 | 1253 | 0.120 |
Why?
| | Arthritis, Rheumatoid | 1 | 2025 | 1169 | 0.120 |
Why?
| | Spleen | 4 | 2014 | 508 | 0.110 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 299 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2021 | 1125 | 0.110 |
Why?
| | Cell Line | 1 | 2020 | 2882 | 0.110 |
Why?
| | Ovum | 2 | 2004 | 31 | 0.100 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 477 | 0.090 |
Why?
| | Muramidase | 1 | 2012 | 67 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2012 | 100 | 0.090 |
Why?
| | CD40 Ligand | 2 | 2003 | 40 | 0.090 |
Why?
| | Caspase 1 | 2 | 2009 | 148 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2016 | 668 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1519 | 0.090 |
Why?
| | Propionibacterium acnes | 2 | 2002 | 10 | 0.090 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 169 | 0.090 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2014 | 389 | 0.080 |
Why?
| | Mice, Nude | 1 | 2013 | 682 | 0.080 |
Why?
| | Lipid A | 1 | 2011 | 28 | 0.080 |
Why?
| | Immunoglobulin E | 1 | 2012 | 315 | 0.080 |
Why?
| | Receptors, CXCR5 | 1 | 2011 | 27 | 0.080 |
Why?
| | Antigens, Bacterial | 2 | 2002 | 125 | 0.080 |
Why?
| | Cell Communication | 1 | 2013 | 324 | 0.080 |
Why?
| | Vaccines, Subunit | 1 | 2011 | 53 | 0.080 |
Why?
| | T-Lymphocyte Subsets | 1 | 2012 | 415 | 0.080 |
Why?
| | B-Lymphocyte Subsets | 1 | 2011 | 80 | 0.080 |
Why?
| | Inflammation | 3 | 2019 | 2878 | 0.080 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2011 | 177 | 0.080 |
Why?
| | Autoimmunity | 1 | 2016 | 926 | 0.080 |
Why?
| | T-Lymphocytes | 3 | 2025 | 1982 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 2 | 2016 | 2363 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2273 | 0.080 |
Why?
| | Injections, Intraperitoneal | 1 | 2009 | 116 | 0.080 |
Why?
| | Female | 12 | 2024 | 78271 | 0.070 |
Why?
| | Neutrophils | 1 | 2015 | 1134 | 0.070 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2155 | 0.070 |
Why?
| | Carrier Proteins | 2 | 2009 | 737 | 0.070 |
Why?
| | Molecular Sequence Data | 2 | 2011 | 2930 | 0.070 |
Why?
| | Immunoglobulin Isotypes | 1 | 2008 | 35 | 0.070 |
Why?
| | Bone Marrow Neoplasms | 1 | 2007 | 3 | 0.070 |
Why?
| | Genes, MHC Class II | 1 | 2008 | 76 | 0.070 |
Why?
| | Biosensing Techniques | 1 | 2009 | 139 | 0.070 |
Why?
| | Neuroblastoma | 1 | 2007 | 174 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 240 | 0.060 |
Why?
| | Interleukin-10 | 2 | 2004 | 309 | 0.060 |
Why?
| | Microscopy, Video | 1 | 2004 | 25 | 0.050 |
Why?
| | Skin Transplantation | 1 | 2025 | 85 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2007 | 623 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2025 | 304 | 0.050 |
Why?
| | Immunophenotyping | 2 | 2003 | 322 | 0.050 |
Why?
| | Neoplastic Stem Cells | 1 | 2007 | 412 | 0.050 |
Why?
| | Bone Marrow Transplantation | 1 | 2025 | 294 | 0.050 |
Why?
| | Toxoplasmosis, Animal | 1 | 2003 | 8 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2004 | 416 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 377 | 0.050 |
Why?
| | Male | 5 | 2024 | 72315 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2004 | 255 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 496 | 0.040 |
Why?
| | Alleles | 1 | 2025 | 879 | 0.040 |
Why?
| | Injections, Subcutaneous | 1 | 2002 | 164 | 0.040 |
Why?
| | Membrane Proteins | 1 | 2007 | 1166 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 1767 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2002 | 320 | 0.040 |
Why?
| | Interleukin-2 | 2 | 2014 | 437 | 0.040 |
Why?
| | Lymphocytic choriomeningitis virus | 2 | 2011 | 36 | 0.040 |
Why?
| | Tertiary Lymphoid Structures | 1 | 2019 | 7 | 0.040 |
Why?
| | A549 Cells | 1 | 2019 | 75 | 0.040 |
Why?
| | Chemokine CXCL13 | 1 | 2019 | 15 | 0.040 |
Why?
| | Interleukin-33 | 1 | 2019 | 45 | 0.040 |
Why?
| | Uric Acid | 1 | 2019 | 166 | 0.030 |
Why?
| | Chemokines | 1 | 2019 | 218 | 0.030 |
Why?
| | Interferon-gamma | 2 | 2014 | 784 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2019 | 395 | 0.030 |
Why?
| | Lymphocytes | 1 | 2019 | 382 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 744 | 0.030 |
Why?
| | Macrophages | 1 | 2024 | 1511 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2019 | 961 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2014 | 202 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2012 | 45 | 0.020 |
Why?
| | Immunological Synapses | 1 | 2012 | 16 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2012 | 198 | 0.020 |
Why?
| | Cell Separation | 1 | 2012 | 307 | 0.020 |
Why?
| | Aerosols | 1 | 2012 | 186 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 636 | 0.020 |
Why?
| | Nucleocapsid Proteins | 1 | 2011 | 28 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3540 | 0.020 |
Why?
| | Viral Core Proteins | 1 | 2011 | 22 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2012 | 574 | 0.020 |
Why?
| | Resting Phase, Cell Cycle | 1 | 2011 | 16 | 0.020 |
Why?
| | Receptors, Lymphocyte Homing | 1 | 2011 | 15 | 0.020 |
Why?
| | Serum Albumin, Bovine | 1 | 2011 | 62 | 0.020 |
Why?
| | Antigens, Surface | 1 | 2011 | 157 | 0.020 |
Why?
| | Salts | 1 | 2010 | 37 | 0.020 |
Why?
| | Orthomyxoviridae Infections | 1 | 2011 | 72 | 0.020 |
Why?
| | Influenza A virus | 1 | 2011 | 113 | 0.020 |
Why?
| | Fibrin | 1 | 2010 | 91 | 0.020 |
Why?
| | Thrombin | 1 | 2010 | 166 | 0.020 |
Why?
| | Fibrinogen | 1 | 2010 | 177 | 0.020 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.020 |
Why?
| | CARD Signaling Adaptor Proteins | 1 | 2009 | 22 | 0.020 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2011 | 264 | 0.020 |
Why?
| | Models, Immunological | 1 | 2009 | 100 | 0.020 |
Why?
| | Antigen-Presenting Cells | 1 | 2009 | 160 | 0.020 |
Why?
| | Adsorption | 1 | 2009 | 157 | 0.020 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 156 | 0.020 |
Why?
| | Lymphocytic Choriomeningitis | 1 | 2008 | 25 | 0.020 |
Why?
| | Cattle | 1 | 2011 | 1000 | 0.020 |
Why?
| | Bcl-2-Like Protein 11 | 1 | 2007 | 37 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 2011 | 462 | 0.020 |
Why?
| | Mice, SCID | 1 | 2007 | 369 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2011 | 780 | 0.020 |
Why?
| | Cell Division | 1 | 2008 | 766 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 2011 | 893 | 0.020 |
Why?
| | Thymus Gland | 1 | 2007 | 311 | 0.020 |
Why?
| | Histones | 1 | 2010 | 669 | 0.010 |
Why?
| | Toll-Like Receptors | 1 | 2004 | 194 | 0.010 |
Why?
| | Ligands | 1 | 2004 | 673 | 0.010 |
Why?
| | Down-Regulation | 1 | 2004 | 627 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2003 | 316 | 0.010 |
Why?
| | Up-Regulation | 1 | 2004 | 851 | 0.010 |
Why?
| | Lipopolysaccharides | 1 | 2004 | 863 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2007 | 2832 | 0.010 |
Why?
| | Phenotype | 1 | 2007 | 3162 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 7173 | 0.010 |
Why?
| | Infant | 1 | 2007 | 10034 | 0.010 |
Why?
|
|
McKee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|